Cvf, Llc - Feb 6, 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)

Role
10%+ Owner
Signature
CVF, LLC, By: HCC Manager LLC, Its: Managing Member, By: /s/ Richard H. Robb, Name: Richard H. Robb, Title: Executive Vice President
Stock symbol
GUTS
Transactions as of
Feb 6, 2024
Transactions value $
$4,999,995
Form type
4
Date filed
2/6/2024, 08:39 PM
Previous filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GUTS Common Stock Conversion of derivative security +3.42M 3.42M Feb 6, 2024 Direct F1, F4
transaction GUTS Common Stock Conversion of derivative security +921K +26.92% 4.34M Feb 6, 2024 Direct F2, F3, F4
transaction GUTS Common Stock Purchase $5M +333K +7.68% $15.00* 4.67M Feb 6, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GUTS Series D Preferred Stock Conversion of derivative security -4.09M -100% 0 Feb 6, 2024 Common Stock Direct F1, F4
transaction GUTS Series E Preferred Stock Conversion of derivative security -2.91M -100% 0 Feb 6, 2024 Common Stock Direct F1, F4
transaction GUTS Series F Preferred Stock Conversion of derivative security -334K -100% 0 Feb 6, 2024 Common Stock Direct F1, F4
transaction GUTS Convertible Promissory Note Conversion of derivative security 0 0 Feb 6, 2024 Common Stock Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's option, on a 1-1 basis, with such ratio being subject to adjustment from time to time for customary events affecting the preferred stock and common stock, and has no expiration date. On January 26, 2024, the Issuer's board approved a 1-for-2.146 reverse stock split of its issued and outstanding shares of common stock, as a result of which the conversion ratio for the Issuer's preferred stock was correspondingly adjusted to 1 share of common stock issuable for 2.146 shares of the preferred stock. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering on February 6, 2024 at such ratio.
F2 The Convertible Note automatically converts into shares of the Issuer's common stock upon the occurrence of certain additional issuances of the Issuer's capital stock, including in connection with an initial public offering of the Issuer's common stock with gross proceeds of at least $80,000,000 or a resulting market capitalization of the Issuer's common stock equal to at least $1,000,000,000. In the event of such an initial public offering, all of the outstanding principal and interest under the convertible note will automatically convert into shares of the Issuer's common stock at a price equal to the lessor of (a) 80% of the per share offering price of common stock in the initial public offering; and (b) the price per share that results when $770,000,000 is divided by the total number of shares of the Issuer's common stock then outstanding, calculated on a fully diluted basis.
F3 (Continued from Footnote 2) Upon the closing of the Issuer's initial public offering on February 6, 2024 meeting the foregoing criteria, the aggregate principal amount of the Convertible Note of approximately $10.9 million, including accrued interest, automatically converted into 920,661 shares of the Issuer's common stock.
F4 HCC Manager LLC, manager of CVF, LLC, exercises voting and investment power with respect to shares held by CVF, LLC. HCC Manager LLC disclaims beneficial ownership of all shares held by CVF, LLC, except to the extent of its pecuniary interest therein.